Combination of in vivo phage therapy data with in silico model highlights key parameters for pneumonia treatment efficacy-Reference-Cited by-同舟云学术

Combination of in vivo phage therapy data with in silico model highlights key parameters for pneumonia treatment efficacy

Published:2022-05 Issue:7 Volume:39 Page:110825
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Delattre Raphaëlle,Seurat Jérémy,Haddad Feyrouz,Nguyen Thu-Thuy,Gaborieau Baptiste^ORCID,Kane Rokhaya,Dufour Nicolas^ORCID,Ricard Jean-Damien^ORCID,Guedj Jérémie,Debarbieux Laurent^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference54 articles.

1. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.;Alemayehu;mBio,2012

2. Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States;Aslam;Open Forum Infect. Dis.,2020

3. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice;Bergeron;Infect. Immun.,1998

4. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models;Bergstrand;AAPS J.,2011

5. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains;Brzuszkiewicz;Proc. Natl. Acad. Sci. U S A,2006

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metapopulation model of phage therapy of an acute Pseudomonas aeruginosa lung infection;mSystems;2024-09-04

2. Variable fitness effects of bacteriophage resistance mutations in Escherichia coli: implications for phage therapy;Journal of Virology;2024-08-30

3. Unraveling host-pathogen dynamics in a murine model of septic peritonitis induced by vancomycin-resistant Enterococcus faecium;Virulence;2024-07

4. New treatment approaches for Clostridioides difficile infections: alternatives to antibiotics and fecal microbiota transplantation;Gut Microbes;2024-04-09

5. Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice;Communications Biology;2024-03-09